More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.96B
EPS
1.88
P/E ratio
8.1
Price to sales
6.34
Dividend yield
10.237%
Beta
0.823858
Previous close
$15.77
Today's open
$15.80
Day's range
$15.63 - $15.86
52 week range
$13.70 - $19.13
show more
CEO
Scott Bluestein
Employees
100
Headquarters
San Mateo, CA
Exchange
New York Stock Exchange
Shares outstanding
189548796
Issue type
Common Stock
Finance
Asset Management Services
Hercules Capital Surpasses $4.0 Billion in Annual Debt and Equity Commitments for First Time in History
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it, together with its private funds managed by its adviser subsidiary, have originated more than $4.0 billion in annual total debt and equity commi.
Business Wire • Nov 17, 2026

Hercules Capital: Accumulation Opportunity At 15% Below Historical P/NAV
Hercules Capital remains a top-tier BDC, outperforming peers in net investment income growth, portfolio expansion, and balance sheet quality. HTGC benefits from positive interest rate sensitivity, with 97.9% of its portfolio in variable-rate loans, positioning it for further NII upside. Despite trading at a premium, HTGC's current P/NAV is ~15% below its 3-year average, offering an attractive entry for income-focused investors.
Seeking Alpha • Nov 13, 2026

11%+ Yields That Are Not Yield Traps
Dividend yields above 11% typically signal significant risks, but occasionally the market offers opportunities to collect exceptionally high income without taking on excessive risk. Strong balance sheets, conservative underlying asset structuring, and proven track records can help protect double-digit dividend payouts. I discuss two compelling income opportunities offering approximately 11% to 12% yields, explain their dividend coverage and risks, and assess why they could deliver attractive long-term total returns.
Seeking Alpha • Nov 12, 2026

2 Elite Income Machines: 9-11% Yields
High yields combined with quality enterprises can be a winning combination. In this article, I highlight two such names that offer the best of both worlds. Both have durable track records of dividends and a robust outlook.
Seeking Alpha • Nov 11, 2026

Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital
BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it has entered into a credit facility agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $200 million. The facility strengthens Atea's financial position and provides strategic and operational flexibility as the Company expands its commercial-related activities in anticipation of the product launch of the regimen of bemnifosbuvir/ruzasvir (BEM/RZR) in the United States (US) for the treatment of chronic hepatitis C virus (HCV), if approved, and advances the Company's clinical program for hepatitis E virus (HEV).
GlobeNewsWire • Nov 9, 2026

Hercules Capital: Earnings Lower, But Credit Holds, Still A Buy
Hercules Capital remains a Buy, but with lower conviction than in August, as fundamentals are clean but per-share NII growth is lacking. Credit quality is strong, with non-accruals minimal and internal grades improving, though leverage increased due to slower repayments. The income stream is steady; Q3 NII was $0.47 per share, down from $0.50 in Q2, mainly due to lower prepayments and higher debt costs.
Seeking Alpha • Nov 5, 2026

Hercules Capital: The Premium Is Still Justified After A Decent Q3
Hercules Capital earns a 'Buy' rating, with a resilient NAV, strong dividend coverage, and sector-leading ROE despite a slow quarter. HTGC trades at a 1.35x NAV premium, justified by 13% annualized ROE and superior credit quality versus peers, with minimal non-accruals. Dividend coverage remains robust at 117% in Q3, with supplemental dividends likely to continue as portfolio growth and income durability persist.
Seeking Alpha • Nov 4, 2026

Hercules Capital: Upgrading To A Buy As Rate Hikes Now Cover Refinancing
I am upgrading Hercules Capital to buy and raising my price target from $15.38 to $16.43, with a full dividend yield of $1.88 on top. HTGC's Q3 NII of $0.47 per share was better than it looks, at $0.485 after adjusting for lower-than-expected early repayments. The loan book expanded by $252.9 million, primarily funded by borrowings, signaling robust portfolio growth.
Seeking Alpha • Nov 2, 2026

Hercules Capital Q3 Earnings Call Highlights
Hercules Capital NYSE: HTGC reported third-quarter 2026 results marked by record year-to-date originations, portfolio growth and stable credit quality, while management said it expects higher investment income and net investment income in the fourth quarter as loan prepayments normalize.
MarketBeat • Oct 30, 2026

Hercules Capital, Inc. (HTGC) Q3 2026 Earnings Call Transcript
Hercules Capital, Inc. (HTGC) Q3 2026 Earnings Call Transcript
Seeking Alpha • Oct 30, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Hercules Capital Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.